It is now known that nasal polyps may be caused by an underlying inflammation called type 2 inflammation. By blocking 2 key sources of type 2 inflammation, DUPIXENT shrinks nasal polyps and reduces the need for surgery.
DUPIXENT was proven to be safe and effective in treating adults with uncontrolled chronic rhinosinusitis with nasal polyps in 2 clinical trials. Find out what benefits were discovered.
DUPIXENT is an innovative treatment with 2 subcutaneous (under the skin) injection administration options.